Area of research
Oncology · Surgery
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Inflammatory Bowel Disease, and Acute Myeloid Leukemia Research.
Real‐World Alcohol Use Disorder Outcomes in Patients With Concurrent Metabolic Dysfunction: <scp>GLP</scp> ‐1 Receptor Agonists Versus <scp>FDA</scp> ‐Approved <scp>AUD</scp> Medications
P-2074. Prevalence and health care utilization outcomes of Z codes in patients with HIV, Tuberculosis Disease, Hepatitis B Virus Infection, and Hepatitis C virus Infection
P-910. Systemic Antibiotic Use Among the Last 30 Days of Life in Patients with Metastatic Cancer
Answering real-world clinical questions using large language model, retrieval-augmented generation, and agentic systems
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
D33. Oncoplastic Breast Surgery: Optimizing Resection Margins in Addition to Aesthetic Outcomes
Screening for Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: Are We Doing Enough?
Estrogen exposure from modern contraceptives and vascular risk in women with migraine: A nationwide electronic medical record database study
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor
Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy compared to other disease modifying therapies
Statin use is associated with reduction in risk of <i>de novo</i> primary sclerosing cholangitis among patients with inflammatory bowel disease: A National Database Study
The Potential Revolution of Cancer Treatment with CRISPR Technology
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Safety and efficacy of immune checkpoint inhibitors (ICI) in advanced penile squamous cell carcinoma (PeCa): An international study from the Global Society of Rare Genitourinary Tumors (GSRGT).
Racial diversity and reporting in FDA registration trials for thoracic malignancies from 2006 to 2020.
The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era